Viridian Therapeutics, Inc.
Extract: Bylaws Amended/Restated (Plain English Desc) from a 10-Q on 05/13/2022   Download
SEC Document
SEC Filing
On May 11, 2022, the board of directors of the Company approved an amendment and restatement of the Company’s Bylaws, effective immediately. The amendments (1) clarify that the voting standard for stockholders to approve all matters other than the election of directors (except as otherwise specified in the Company’s Certificate of Incorporation or Bylaws or Delaware law) is a majority of votes cast, (2) clarify that the chairman of the meeting has the power to adjourn a meeting of stockholders in the absence of a quorum, and (3) make certain other ministerial changes.